At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study of Clinical Features and Outcome of Interstitial Lung Disease With Anti-neutrophil Cytoplasmic Antibody in Chinese Patients.
In Brief
An observational study for Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate the clinical features and long-term outcome of anti-neutrophil cytoplasmic antibody (ANCA)-positive interstitial lung disease (ILD) and assess the difference between microscopic polyangiitis (MPA) associated ILD and isolated ANCA-positive idiopathic interstitial pneumonia.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartApr 2014
Primary CompletionApr 2019
Study CompletionApr 2020
First PostedJun 2020
TodayJul 2026
First PostedJun 2, 2020
Enrollment StartApr 1, 2014
Primary CompletionApr 1, 2019
Study CompletionApr 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 6.1 years ago